Yesterday, The New York Times informed us that a small drug company called Allos is charging $30,000 a month for a cancer drug, Folotyn, that treats a rare and usually fatal form of cancer that strikes fewer that 6,000 American a year. It doesn’t cure the cancer, but merely slows it down; even with that, victims seldom survive more than a few months. “This drug is not a home run. It’s not even a double. It’s a single,” the Times quotes Dr. Brad S. Kahl, a lymphoma specialist at the University of Wisconsin, as saying. Continue reading
Health and Medicine
The Savage Saga: Wrong Embryo Ethics Unresolved
The disturbing story of Carolyn and Sean Savage’s pregnancy was a hot topic in September, but it is barely remembered now. I am hoping that bioethicists and legal specialists are still cogitating over it, however, because the ethical and legal issues aren’t going away. They are probably just around the corner. Continue reading
“Biggest Loser” Ethics: “They Shoot Fat People, Don’t They?”
Lawyers being lawyers, it is not surprising that a New York Times article about the unhealthy physical stresses endured by contestants in the “Biggest Loser” reality show inspired a legal blog to wonder how long it would be before the show was hit with a large law suit. “I’m waiting for the first person to have a heart attack,” THR, ESQ quotes Dr. Charles Burant, a professor of internal medicine at the University of Michigan, as saying. The core problem is not liability, however. The problem is that the show is horribly, indefensibly unethical. It shouldn’t be waiting for a lawsuit, or a heart attack. The program is wrong to continue, advertisers are wrong to support it, and we are wrong to watch it. Continue reading
Ethics Heroes: “Pharmed Out”
A group of 100 medical ethicists, physicians and others calling themselves Pharmed Out have written the head of the National Institutes of Health and requested that the NIH fund studies examining the effect financial and industrial conflicts of interest have on medical research. Continue reading
Lobbyist Ventriloquism and the Abysmal State of Congressional Ethics
When Washington, D.C. attorney Robert Trout delivered his closing argument in the trial of former Rep. William Jefferson (now known as “Inmate CB476881”) for, among other things, accepting a large cash bribe that was later found in his office freezer, he told the jury that the prosecution was hypocritical and unfair. After all, he said, “If seeking political help was a crime, you could lock up half of metropolitan Washington, D.C.” Jefferson’s actions may have been unethical, and they were certainly a mistake, but really now: isn’t this just what all Congressmen do? Jefferson, Trout argued, just got a little bit carried away.
Jefferson was convicted, so there is some distance left for our faith in our elected representatives to fall before it hits rock bottom. The argument was still ethically disturbing in two respects. First of all, Trout’s pitch amounted to a jury nullification plea, a defense in which a jury is encouraged to ignore the law, and that is unethical lawyering.
Second, Trout may well have been right. Continue reading
Breast Cancer Screening Standards and Conflicts of Interest
From Reuters: CHICAGO – Cancer experts fear new U.S. breast imaging guidelines that recommend against routine screening mammograms for women in their 40s may have their roots in the current drive in Washington to reform healthcare…
The decision of the U.S. Preventative Services Task Force, an influential group that crafts guidelines for doctors, insurance companies and policymakers, to backtrack on decades of medical advice urging women to begin getting regular mammograms at the age of 40 has stirred debate and anger. The most alarming aspect of the report, however, is that the new standards being put forth may reflect U.S. health care cost management considerations rather than proper concern for the health of U.S. women. Continue reading
Sally Harpold, Chaos, and the Ethics of Law-making
As we contemplate a House health care reform bill that is over 2,000 pages long, it might be a good time to revisit the cautionary tale of Indiana grandmother Sally Harpold, and its lessons about law, fairness, responsibility, and Chaos Theory, not to mention ethics. Continue reading
Player Dementia and the Fan’s Dilemma: Is Watching N.F.L. Football Unethical?
It is Sunday, and much of America is ready to settle in front of millions of wide-screen, high-definition television sets to watch Sunday’s favorite entertainment: NFL football. The last thing football fans want to think about today is ethics, and today, perhaps, they shouldn’t have to. Although we are not there yet, the time is fast approaching when not only football fans, but the companies that buy commercials, the merchandisers that sell NFL-licensed jerseys and posters, the TV networks, and the nation itself may have to consider a difficult ethics question: is supporting pro-football unethical? Continue reading
